168 related articles for article (PubMed ID: 33920701)
1. Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy.
Posteraro B; De Angelis G; Menchinelli G; D'Inzeo T; Fiori B; De Maio F; Cortazzo V; Sanguinetti M; Spanu T
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920701
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections.
Marra AR; Bearman GM; Wenzel RP; Edmond MB
BMC Infect Dis; 2005 Oct; 5():94. PubMed ID: 16259623
[TBL] [Abstract][Full Text] [Related]
3. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
5. Hospital-acquired bloodstream infections in patients deceased with COVID-19 in Italy (2020-2021).
Monaco M; Floridia M; Giuliano M; Palmieri L; Lo Noce C; Pantosti A; Palamara AT; Brusaferro S; Onder G;
Front Med (Lausanne); 2022; 9():1041668. PubMed ID: 36465906
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID).
Abelenda-Alonso G; Rombauts A; Gudiol C; Oriol I; Simonetti A; Coloma A; Rodríguez-Molinero A; Izquierdo E; Díaz-Brito V; Sanmartí M; Padullés A; Grau I; Ras M; Bergas A; Guillem L; Blanco-Arévalo A; Alvarez-Pouso C; Pallarés N; Videla S; Tebé C; Carratalà J
Clin Microbiol Infect; 2021 Nov; 27(11):1685-1692. PubMed ID: 34242804
[TBL] [Abstract][Full Text] [Related]
7. Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study).
Falcone M; Suardi LR; Tiseo G; Galfo V; Occhineri S; Verdenelli S; Ceccarelli G; Poli M; Merli M; Bavaro D; Carretta A; Nunnari G; Venanzi Rullo E; Trecarichi EM; Papalini C; Franco A; Del Vecchio RF; Bianco V; Punzi R; Francisci D; Rubino R; Torti C; Puoti M; Carbonara S; Cascio A; Saracino A; Santantonio T; Venditti M; Menichetti F
JAC Antimicrob Resist; 2022 Jun; 4(3):dlac064. PubMed ID: 35719203
[TBL] [Abstract][Full Text] [Related]
8.
Ioannou P; Alexakis K; Maraki S; Kofteridis DP
Antibiotics (Basel); 2023 Mar; 12(4):. PubMed ID: 37107032
[No Abstract] [Full Text] [Related]
9. Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria.
Piantoni A; Houard M; Piga G; Zebian G; Ruffier des Aimes S; Holik B; Wallet F; Rouzé A; Kreitmann L; Loiez C; Labreuche J; Nseir S
Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508201
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis.
Bartoletti M; Giannella M; Caraceni P; Domenicali M; Ambretti S; Tedeschi S; Verucchi G; Badia L; Lewis RE; Bernardi M; Viale P
J Hepatol; 2014 Jul; 61(1):51-8. PubMed ID: 24681345
[TBL] [Abstract][Full Text] [Related]
11. Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.
Thaden JT; Park LP; Maskarinec SA; Ruffin F; Fowler VG; van Duin D
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373189
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance Profiles and Comparative Analysis of Risk Factors and Patients' Outcome.
Giannitsioti E; Louka C; Mamali V; Kousouli E; Velentza L; Papadouli V; Loizos G; Mavroudis P; Kranidiotis G; Rekleiti N; Stamati A; Speggos I; Daniil I; Kouvatsos P; Sidiropoulou C; Linardaki G; Gerakari S; Chrysos G; Themeli-Digalaki K; Zarkotou O
Microorganisms; 2022 Jun; 10(7):. PubMed ID: 35889033
[TBL] [Abstract][Full Text] [Related]
13. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
14. Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015-2020: COVID-19 Aftermath.
Chamieh A; Zgheib R; El-Sawalhi S; Yammine L; El-Hajj G; Zmerli O; Afif C; Rolain JM; Azar E
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439065
[TBL] [Abstract][Full Text] [Related]
15. Effect of bloodstream infection on survival in COVID-19 patients admitted to an intensive care unit in Colombia: a matched cohort analysis.
Cortes JA; Valderrama-Rios MC; Nocua-Báez LC; Quitián LM; Lozada FA; Buitrago G
Infect Prev Pract; 2023 Jun; 5(2):100283. PubMed ID: 37197192
[TBL] [Abstract][Full Text] [Related]
16. The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the Evidence.
Coulter S; Roberts JA; Hajkowicz K; Halton K
Infect Dis Rep; 2017 Mar; 9(1):6849. PubMed ID: 28458799
[TBL] [Abstract][Full Text] [Related]
17. Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study.
Falcone M; Tiseo G; Dentali F; Foglia E; Campanini M; Menichetti F; Mazzone A;
J Glob Antimicrob Resist; 2019 Sep; 18():139-144. PubMed ID: 30825701
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of antibiotic-resistant bacteria in south-east Sweden: An epidemiologic study on 9268 cases of bloodstream infection.
Holmbom M; Möller V; Nilsson LE; Giske CG; Rashid MU; Fredrikson M; Hällgren A; Hanberger H; Balkhed ÅÖ
PLoS One; 2020; 15(3):e0230501. PubMed ID: 32218575
[TBL] [Abstract][Full Text] [Related]
19. Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.
Saliba M; Saadeh D; Bouchand F; Davido B; Duran C; Clair B; Lawrence C; Annane D; Denys P; Salomon J; Bernard L; Dinh A
Spinal Cord; 2017 Feb; 55(2):148-154. PubMed ID: 27995941
[TBL] [Abstract][Full Text] [Related]
20. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
